BioInsights - Closing the window of vulnerability: better vaccine adjuvants for neonates

Closing the window of vulnerability: better vaccine adjuvants for neonates

Vaccine Insights 2022; 1(2), 127–129

DOI: 10.18609/vac.2022.021

Published: 17 June 2022
Viewpoint
Kiva Brennan

Although it is well known that immune responses differ dramatically with age, most vaccines are still developed with the adult immune system in mind. To protect the most vulnerable in our society, we need to consider their unique needs when developing vaccines and adjuvants.

“Ultimately, we need pediatric-specific vaccines if we are to best serve children’s health.”